Dr. Roy Rubinfeld set out many years ago to invent a better treatment to help millions of people with keratoconus. In 2009, he founded the world’s largest research group - CXLUSA- dedicated to developing safer, fast recovery, less invasive treatments for this common condition and has been an international pioneer of advanced corneal crosslinking. Years ago, a diagnosis of progressive keratoconus left patients with few treatment options.
Schedule Free ConsultI Have Kera-What?
"I tried to tell them. I couldn't see well out of that eye even with new glasses and the doctor said I just had astigmatism. Then it got worse and started in the other eye. I didn't know how to describe it so they would understand, but it was starting to look like this."
Keratoconus is an eye condition caused by weakened, thinning corneas that take on a cone-like shape, causing progressively worsening distorted vision. It is common and affects approximately 1 in 84 Americans. Early detection is vital to protecting vision from loss caused by keratoconus. Dr. Rubinfeld founded the world’s largest keratoconus research study group, CXLUSA, which developed the only epithelium-on crosslinking (CXL) system, shown in large research studies to be highly effective in stopping keratoconus vision loss and avoiding the risks and slow recovery of surgical removal of the corneal epithelium.
Schedule Free Consult
Dr. Roy Rubinfeld founded the world’s largest keratoconus research study group CXLUSA, dedicated to less invasive epithelium-on corneal crosslinking (CXL) that avoids the risks and slow recovery of removing the cornea’s protective layer. He and the CXLUSA research group were the inventors of epithelium-on CXL found to stop vision loss in large published research trials.
The only treatment found to be effective in stopping vision loss from keratoconus is crosslinking (CXL), which strengthens the weak cornea. The original form of this procedure, introduced in 1998, involves surgically scraping off the protective surface layer, or epithelium, of the cornea to get vitamin B2 (riboflavin) drops into the cornea and applying a small amount of UV light similar to sunlight.
Take our Free Self-Test
More recently, epithelium-on CXL has been developed and investigated, which leaves the protective epithelium in place. Learn more about this procedure and the latest research in keratoconus treatment from CXLUSA.
Epithelium-on crosslinking recovery time has been shown to be much faster and more comfortable when compared with patient experiences after an epithelium-off procedure.
Re:Vision offers expertise where it matters most — your vision.
Dr. Rubinfeld is known worldwide for keratoconus research and treatment and was among the first in the D.C. area to get involved in laser vision correction.
You’ll want to see the best to see your best. Dr. Rubinfeld has held the trust of tens of thousands of patients for more than 25 years.
Schedule Free Consult
"Dr. Rubinfeld is kind, professional, and extremely detail-oriented. He makes sure you fully understand and agree to every treatment being performed, so there are no surprises. His staff is amazingly kind and work tirelessly to ensure your 100% comfort throughout the procedure. I wish I had found Dr. Rubinfeld 10 years ago."
Tim
"I was referred to Dr. Rubinfeld for epithelium-on cross-linking which he invented and CK corneal reshaping. I was impressed with the care I received from Dr. Rubinfeld and his staff and absolutely amazed at the healing time after having both my eyes done with these advanced procedures. The day after, I had no pain. I highly recommend Dr. Rubinfeld and his cutting-edge techniques to treat keratoconus."
Eric
Research Neuro-Psychologist
“He and his wonderful, caring team were amazing. The day after the Epithelium-On procedure I had no pain, irritation, or blurriness.”
James
Doctor of Dental Medicine
Questions/Comments?
Call or Text us Today!